

| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivasundaran Venkatesh Appointed as Managing Director since October 2015 | Managing Director | 05-Oct-2015 | Current |
Alamelu Sathya Priya Appointed as Director since February 2008 | Director | 20-Feb-2008 | Current |
Balabanumathi Venkatesh Appointed as Director since July 2007 | Director | 17-Jul-2007 | Current |
Raju Ranganathan Appointed as Director since August 2022 | Director | 25-Aug-2022 | Current |
Sathiyamurthi Vanisaraswathi Appointed as Director since February 2008 | Director | 20-Feb-2008 | Current |
Srinivasan Ashalatha Appointed as Director since June 2012 | Director | 01-Jun-2012 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Hibiscus Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Hibiscus Pharmaceuticals Private Limited's leadership journey.
Loading...
Contact Details
- Address New No -2, Old No-25 / 1,, Elango Nagar, First Street, Virugambakkam,, Chennai Tamil Nadu, 600092, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 600092
- Country India
- Website hibiscuspharmaceuticals.com
Frequently Asked Questions
You can contact Hibiscus Pharmaceuticals Private Limited through their registered address at New No -2, Old No-25 / 1,, Elango Nagar, First Street, Virugambakkam,, Chennai Tamil Nadu, 600092, India, or via their website at hibiscuspharmaceuticals.com. Social media links are also provided where applicable.
The current directors of Hibiscus Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- BALABANUMATHI VENKATESH
- ALAMELU SATHYA PRIYA
- RAJU RANGANATHAN
- SATHIYAMURTHI VANISARASWATHI
- SRINIVASAN ASHALATHA
- SIVASUNDARAN VENKATESH
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.